PRESS RELEASE published on 06/13/2025 at 01:00, 5 months 22 days ago BioNxt Solutions Provides Bi-Weekly MCTO Status Report BioNxt Solutions provides an update on the management cease trade order from BCSC, ensuring efforts to file required financial documents by June 30, 2025 Management Cease Trade Order BCSC Filing Deadline Financial Documents BioNxt Solutions
BRIEF published on 05/30/2025 at 01:05, 6 months 6 days ago BioNxt Solutions met à jour le statut de l'ordonnance de cessation d'opérations de la direction MCTO BCSC Solutions BioNxt Dépôt De Documents Financiers Progression De L'audit
BRIEF published on 05/30/2025 at 01:05, 6 months 6 days ago BioNxt Solutions Updates on Management Cease Trade Order Status MCTO Financial Filing BCSC BioNxt Solutions Audit Progress
PRESS RELEASE published on 05/30/2025 at 01:00, 6 months 6 days ago BioNxt Solutions Provides Bi-weekly MCTO Status Report BioNxt Solutions Inc. announces management cease trade order by BCSC until required financial statements are filed. Company's progress on compliance and commitment to regulation outlined Financial Statements Regulatory Compliance Management Cease Trade Order BCSC BioNxt Solutions Inc.
BRIEF published on 05/23/2025 at 09:10, 6 months 13 days ago BioNxt Solutions s'apprête à obtenir un brevet européen pour son système d'administration de médicaments Sclérose En Plaques Développement De Médicaments Solutions BioNxt Brevet Européen Administration Sublinguale
BRIEF published on 05/23/2025 at 09:10, 6 months 13 days ago BioNxt Solutions Set to Receive European Patent for Drug Delivery System Drug Development Multiple Sclerosis European Patent BioNxt Solutions Sublingual Delivery
PRESS RELEASE published on 05/23/2025 at 09:05, 6 months 13 days ago BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent BioNxt Solutions Inc. announces European Patent Office's intention to grant their core patent for advanced drug delivery systems, focusing on sublingual anticancer treatments BioNxt Solutions Inc. European Patent Office Drug Delivery Systems Sublingual Anticancer Treatments
BRIEF published on 05/16/2025 at 01:35, 6 months 20 days ago BioNxt Solutions fournit une mise à jour du statut MCTO MCTO États Financiers Conformité Réglementaire Processus D'audit Informations Aux Actionnaires
BRIEF published on 05/16/2025 at 01:35, 6 months 20 days ago BioNxt Solutions Provides MCTO Status Update Financial Statements Regulatory Compliance Shareholder Information MCTO Audit Process
PRESS RELEASE published on 05/16/2025 at 01:30, 6 months 20 days ago Bionxt Solutions Provides Bi-Weekly MCTO Status Report BioNxt Solutions Inc. announces a management cease trade order granted by the BC Securities Commission affecting the CEO and CFO from trading until Required Documents filed by June 30, 2025 Management Cease Trade Order BioNxt Solutions Inc. Filing Deadline BC Securities Commission Required Documents
Published on 12/05/2025 at 23:30, 3 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 21:45, 1 hour 48 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 3 minutes ago The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours 13 minutes ago Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 22:15, 1 hour 17 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 21 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours 35 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 5 hours 17 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 33 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 33 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 33 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 33 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 15 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
